BBL
GH icon

Beck Bode LLC’s Guardant Health GH Stock Holding History

Beck Bode LLC’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-248,859
Closed -$5.71M – 121
2024
Q3 		$5.71M Sell
248,859
-20,531
-8% -$581K 1.07% 34
2024
Q2 		$7.78M Buy
269,390
+65,794
+32% +$1.53M 1.56% 26
2024
Q1 		$4.2M Buy
203,596
+60,851
+43% +$1.3M 0.86% 36
2023
Q4 		$3.86M Buy
+142,745
New +$3.74M 0.87% 39
2021
Q3 		– Sell
-250
Closed -$31K – 163
2021
Q2 		$31K Buy
+250
New +$33.6K 0.01% 161
2020
Q4 		– Sell
-225
Closed -$25K – 116
2020
Q3 		$25K Buy
+225
New +$20.6K 0.01% 152

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Beck Bode LLC's GH Position: Q4 2024 in Review

Beck Bode LLC sold out of Guardant Health (GH) in Q4 2024, closing a stake of 248,859 shares — an estimated $5.71M sold.

Beck Bode LLC first reported a position in GH in Q3 2020 and held it in 6 quarters. The position peaked at $7.78M in Q2 2024. 298 funds tracked by Wall St. Rank hold GH as of Q4 2024.

  • Beck Bode LLC reported no remaining Guardant Health position as of Q4 2024 after selling out during the quarter.
  • Beck Bode LLC sold 248,859 Guardant Health shares in Q4 2024, an estimated $5.71M.
  • Beck Bode LLC first reported a position in Guardant Health in Q3 2020 and held it in 6 quarters.
  • Beck Bode LLC's Guardant Health position peaked at $7.78M in Q2 2024.
  • 298 funds tracked by Wall St. Rank held Guardant Health as of Q4 2024.

Based on Beck Bode LLC's 13F filing for Q4 2024, filed 14 Feb 2025.